Geode Capital Management, LLC Caribou Biosciences, Inc. Transaction History

Geode Capital Management, LLC

$1.24 Trillion
Q1 2025

A detailed history of Geode Capital Management, LLC transactions in Caribou Biosciences, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 2,053,929 shares of CRBU stock, worth $1.77 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,053,929

Previous 1,972,395 4.13%

Holding current value

$1.77 Million

Previous $3.14 Million 40.4%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 13, 2025	BUY	$0.88 - $1.88 $71,749 - $153,283	81,534 Added 4.13%	2,053,929 $1.87 Million
Q4 2024 Feb 12, 2025	SELL	$1.59 - $2.79 $92,296 - $161,953	-58,048 Reduced 2.86%	1,972,395 $3.14 Million
Q3 2024 Nov 12, 2024	BUY	$1.56 - $2.73 $194,659 - $340,654	124,782 Added 6.55%	2,030,443 $3.96 Million
Q2 2024 Aug 09, 2024	BUY	$1.62 - $5.05 $102,834 - $320,563	63,478 Added 3.45%	1,905,661 $3.13 Million
Q1 2024 May 13, 2024	BUY	$4.82 - $8.26 $229,118 - $392,639	47,535 Added 2.65%	1,842,183 $9.47 Million
Q4 2023 Feb 13, 2024	BUY	$3.58 - $6.25 $778,675 - $1.36 Million	217,507 Added 13.79%	1,794,648 $10.3 Million
Q3 2023 Nov 13, 2023	BUY	$4.08 - $8.14 $1.9 Million - $3.79 Million	465,590 Added 41.89%	1,577,141 $7.54 Million
Q2 2023 Aug 11, 2023	BUY	$4.04 - $5.47 $169,385 - $229,340	41,927 Added 3.92%	1,111,551 $4.72 Million
Q1 2023 May 15, 2023	BUY	$4.3 - $7.78 $166,139 - $300,595	38,637 Added 3.75%	1,069,624 $5.68 Million
Q4 2022 Feb 13, 2023	BUY	$5.57 - $11.01 $254,086 - $502,243	45,617 Added 4.63%	1,030,987 $6.47 Million
Q3 2022 Nov 14, 2022	BUY	$5.34 - $12.79 $1.66 Million - $3.97 Million	310,597 Added 46.03%	985,370 $10.4 Million
Q2 2022 Aug 12, 2022	BUY	$5.1 - $9.74 $132,681 - $253,395	26,016 Added 4.01%	674,773 $3.66 Million
Q1 2022 May 13, 2022	BUY	$8.42 - $15.32 $2.42 Million - $4.4 Million	287,125 Added 79.4%	648,757 $5.96 Million
Q4 2021 Feb 11, 2022	BUY	$14.59 - $23.26 $283,294 - $451,639	19,417 Added 5.67%	361,632 $5.46 Million
Q3 2021 Nov 12, 2021	BUY	$15.75 - $30.29 $5.39 Million - $10.4 Million	342,215 New	342,215 $8.17 Million

Others Institutions Holding CRBU

# of Institutions

135

Shares Held

47M

Call Options Held

17.1K

Put Options Held

58.1K

View Full List

About Caribou Biosciences, Inc.

Ticker CRBU
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 60,840,800
Market Cap $52.3M
Description
Caribou Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of genome-edited allogeneic cell therapies for the treatment of hematologic malignancies and solid tumors in the United States and internationally. Its lead product candidates are CB-010, an allogeneic anti-CD19 CAR-T cell therapy that is in phase 1...

More about CRBU

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Account

Geode Capital Management, LLC Caribou Biosciences, Inc. Transaction History